Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Current Opinion in Structural Biology
|
September 2, 2003
Designing proteins for therapeutic applications
Greg A Lazar, Shannon A Marshall, Joseph J Plecs, et al.
Molecular Cancer Therapeutics
|
August 30, 2008
Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells
John O Richards, Sher Karki, Greg A Lazar, et al.
Immunology Letters
|
February 7, 2012
Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb
Saso Cemerski, Seung Y Chu, Gregory L Moore, et al.
The Journal of Biological Chemistry
|
December 16, 2005
Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion
Gang Song, Greg A Lazar, Tanja Kortemme, et al.
Mabs
|
February 5, 2014
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity
Stefanie Derer, Pia Glorius, Martin Schlaeth, et al.
Molecular Immunology
|
August 12, 2008
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies
Seung Y Chu, Igor Vostiar, Sher Karki, et al.
Blood
|
December 26, 2008
The impact of Fc engineering on an anti-CD19 antibody: increased Fcgamma receptor affinity enhances B-cell clearing in nonhuman primates
Jonathan Zalevsky, Irene W L Leung, Sher Karki, et al.
Nature Biotechnology
|
January 19, 2010
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky, Aaron K Chamberlain, Holly M Horton, et al.
Blood
|
July 10, 2010
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies
Holly M Horton, Matthew J Bernett, Matthias Peipp, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 2, 2011
Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus
Holly M Horton, Seung Y Chu, Elizabeth C Ortiz, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Current Opinion in Structural Biology
|
September 2, 2003
Designing proteins for therapeutic applications
Greg A Lazar, Shannon A Marshall, Joseph J Plecs, et al.
Molecular Cancer Therapeutics
|
August 30, 2008
Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells
John O Richards, Sher Karki, Greg A Lazar, et al.
Immunology Letters
|
February 7, 2012
Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb
Saso Cemerski, Seung Y Chu, Gregory L Moore, et al.
The Journal of Biological Chemistry
|
December 16, 2005
Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion
Gang Song, Greg A Lazar, Tanja Kortemme, et al.
Mabs
|
February 5, 2014
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity
Stefanie Derer, Pia Glorius, Martin Schlaeth, et al.
Molecular Immunology
|
August 12, 2008
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies
Seung Y Chu, Igor Vostiar, Sher Karki, et al.
Blood
|
December 26, 2008
The impact of Fc engineering on an anti-CD19 antibody: increased Fcgamma receptor affinity enhances B-cell clearing in nonhuman primates
Jonathan Zalevsky, Irene W L Leung, Sher Karki, et al.
Nature Biotechnology
|
January 19, 2010
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky, Aaron K Chamberlain, Holly M Horton, et al.
Blood
|
July 10, 2010
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies
Holly M Horton, Matthew J Bernett, Matthias Peipp, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 2, 2011
Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus
Holly M Horton, Seung Y Chu, Elizabeth C Ortiz, et al.
Page
of 6